ArticleOncotarget2017

CD164 promotes lung tumor-initiating cells with stem cell activity and determines tumor growth and drug resistance via Akt/mTOR signaling.

Wei-Liang Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.